Recent Analyst Forecasts and Stock Ratings
CRISPR Therapeutics AG FAQ's
CRISPR Therapeutics AG has been rated by research analysts at Bernstein, Evercore ISI, Morgan Stanley, Chardan Capital, Needham, RBC Capital in the past 90 days.
CRISPR Therapeutics AG has been rated by research analysts at Bernstein, Evercore ISI, Morgan Stanley, Chardan Capital, Needham, RBC Capital in the past 90 days.